Are you making the most of the latest clinical tools from the multi-society Cardio-Kidney-Metabolic (CKM) Initiative led by the ISN? The CKM Initiative addresses gaps in therapy, management, and implementation — supporting clinicians and advancing care for patients with CKM conditions. It includes an interactive CKM roadmap to guide the management of patients with cardio-kidney-metabolic...
The ISN Academy presents a comprehensive new course on monoclonal gammopathy of renal significance (MGRS) and amyloidosis, designed to equip healthcare professionals with critical knowledge on these rare but impactful conditions. Access the course here It features case-based, 20-minute recorded talks on key topics, including: The pathogenesis, diagnosis, and classification of MGRS subtypes—such as MIDD, PGNMID, C3G,...
The Optimization of SGLT2i Therapy Toolkit* is the latest educational offering from a multi-society cardio-kidney-metabolic initiative led by the ISN. This initiative offers resources for advancing the prevention and management of cardio-kidney-metabolic complications. The toolkit highlights the crucial role of SGLT2 inhibitors in improving outcomes for patients with both kidney and cardiovascular diseases. The SGLT2i...
The ISN has expanded its “Cardio-Kidney-Metabolic (CKM) Initiative” with the launch of a new interactive CKM roadmap designed to help clinicians manage patients with cardio-kidney-metabolic conditions and complications. Access the roadmap here Kidney, cardiovascular, and metabolic diseases are closely linked, contributing significantly to morbidity and mortality worldwide. Launched in 2022, the CKM initiative brings nephrologists and...
The ISN has added two new webinars to its Rare Kidney Disease Toolkit, focusing on immunoglobulin A nephropathy (IgAN) and C3 glomerulopathy (C3G). These expert-led sessions offer valuable insights into diagnosing, managing, and treating these rare but challenging kidney diseases. Watch "Advancements in C3 Glomerulopathy (C3G)," featuring David Kavanagh (UK), Alison Ma (Hong Kong), and...
The Rare Kidney Diseases Toolkit* curates resources to raise the profile and understanding of rare kidney diseases. It offers disease-specific tools and highlights the burden, gaps, and unmet needs that need to be addressed. Access the toolkit here Tools include infographics, webinars, and the EACCME-accredited ISN Complement Pathway Disease Curriculum, which reviews the pathophysiology, diagnosis and...
The toolkit on optimizing RAASi therapy and managing associated complications offers user-friendly infographics in Chinese, English, Spanish and Japanese. Access the Optimization of RAASi Therapy Toolkit here These visual aids serve as practical references for nephrologists, cardiologists, and other healthcare professionals caring for patients with heart and kidney conditions. The toolkit comprises five practical infographics, including...
The kidney is particularly susceptible to damage by complement. Activation of the complement system is tightly regulated by a series of soluble and membrane-bound proteins. Failure of these checking mechanisms is one of the major causes of complement-mediated kidney diseases. Evidence of specific complement activity has been identified in several kidney diseases, including IgA nephropathy,...
